2018 - Distinguished Scientist Award, American Heart Association
John A. Spertus focuses on Internal medicine, Myocardial infarction, Cardiology, Percutaneous coronary intervention and Heart failure. His Internal medicine study integrates concerns from other disciplines, such as Physical therapy, Surgery and Depression. His work deals with themes such as Odds ratio, Mortality rate, Hazard ratio and Emergency medicine, which intersect with Myocardial infarction.
The concepts of his Cardiology study are interwoven with issues in Diabetes mellitus, Logistic regression and Disease. His Percutaneous coronary intervention research incorporates elements of Conventional PCI, Angioplasty, Clinical endpoint, Randomized controlled trial and Revascularization. His Heart failure study combines topics from a wide range of disciplines, such as Severity of illness, Ambulatory care, Proportional hazards model and Intensive care medicine.
John A. Spertus mainly investigates Internal medicine, Myocardial infarction, Cardiology, Heart failure and Physical therapy. His work in the fields of Angina, Percutaneous coronary intervention, Quality of life and Conventional PCI overlaps with other areas such as In patient. His Myocardial infarction study integrates concerns from other disciplines, such as Diabetes mellitus, Intensive care medicine, Confidence interval, Emergency medicine and Prospective cohort study.
His biological study spans a wide range of topics, including Surgery and Hazard ratio. His Heart failure study focuses on Ejection fraction in particular. His study in Physical therapy is interdisciplinary in nature, drawing from both Clinical trial, Disease, Cohort and Depression.
Internal medicine, Cardiology, Heart failure, In patient and Quality of life are his primary areas of study. Percutaneous coronary intervention, Myocardial infarction, Coronary artery disease, Disease and Angina are the primary areas of interest in his Internal medicine study. His research in Percutaneous coronary intervention intersects with topics in Angioplasty, Conventional PCI, Acute kidney injury and Emergency medicine.
His work focuses on many connections between Disease and other disciplines, such as Claudication, that overlap with his field of interest in Physical therapy. John A. Spertus works mostly in the field of Heart failure, limiting it down to topics relating to Intensive care medicine and, in certain cases, Quality of life. His Quality of life research focuses on Destination therapy and how it connects with Visual analogue scale.
John A. Spertus spends much of his time researching Internal medicine, Cardiology, Percutaneous coronary intervention, Quality of life and Heart failure. His work on Coronary artery disease, Myocardial infarction, Angina and Revascularization as part of general Internal medicine research is often related to In patient, thus linking different fields of science. His Cardiology study incorporates themes from Stroke and Retrospective cohort study.
His Percutaneous coronary intervention research is multidisciplinary, relying on both Conventional PCI, Angioplasty, Kidney disease, Cardiac catheterization and Appropriate Use Criteria. His studies in Quality of life integrate themes in fields like Intermittent claudication, Physical therapy, Atrial fibrillation and Confidence interval. His Heart failure research integrates issues from Logistic regression and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
Stephan D. Fihn;Julius M. Gardin;Jonathan Abrams;Kathleen Berra.
Circulation (2012)
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and American College of Cardiology Foundation
Sidney C. Smith;Emelia J. Benjamin;Robert O. Bonow;Lynne T. Braun.
Circulation (2011)
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
Leslee J. Shaw;Daniel S. Berman;David J. Maron;G. B. John Mancini.
Circulation (2008)
Initial invasive or conservative strategy for stable coronary disease.
David J. Maron;Judith S. Hochman;Harmony R. Reynolds;Sripal Bangalore.
The New England Journal of Medicine (2020)
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
Sidney C. Smith;Emelia J. Benjamin;Robert O. Bonow;Lynne T. Braun.
Journal of the American College of Cardiology (2011)
Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry
John A. Spertus;Richard Kettelkamp;Clifton Vance;Carole Decker.
Circulation (2006)
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial.
Kathryn E. Flynn;Ileana L. Piña;David J. Whellan;David J. Whellan;Li Lin.
JAMA (2009)
ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography
Manesh R. Patel;Gregory J. Dehmer;John W. Hirshfeld;Peter K. Smith.
Journal of the American College of Cardiology (2012)
Impact of medication therapy discontinuation on mortality after myocardial infarction.
P. Michael Ho;John A. Spertus;Frederick A. Masoudi;Frederick A. Masoudi;Kimberly J. Reid.
JAMA Internal Medicine (2006)
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
Stephan D. Fihn;Julius M. Gardin;Jonathan Abrams;Kathleen Berra.
Circulation (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Yale University
University of Colorado Anschutz Medical Campus
University of Colorado Denver
University of Missouri–Kansas City
Georgetown University
University of Missouri–Kansas City
University of East Anglia
University of Michigan–Ann Arbor
Duke University
McMaster University
Columbia University
University of Queensland
London School of Economics and Political Science
Tohoku University
University of Michigan–Ann Arbor
University of Pennsylvania
Kyoto University
University of Toronto
ASM International
University of California, Berkeley
Vrije Universiteit Amsterdam
New York University
University of Iowa
Spanish National Research Council
Yale University
University of Birmingham